Beyer U - Search Results

1

Bayesian adaptive designs in single ascending dose trials in healthy volunteers.

Guédé D, Reigner B, Vandenhende F, Derks M, Beyer U, Jordan P, Worth E, Diack C, Frey N, Peck R. Guédé D, et al. Among authors: beyer u. Br J Clin Pharmacol. 2014 Aug;78(2):393-400. doi: 10.1111/bcp.12344. Br J Clin Pharmacol. 2014. PMID: 24528176 Free PMC article.

2

Bayesian adaptive dose-escalation procedures for binary and continuous responses utilizing a gain function.

Yeung WY, Whitehead J, Reigner B, Beyer U, Diack C, Jaki T. Yeung WY, et al. Among authors: beyer u. Pharm Stat. 2015 Nov-Dec;14(6):479-87. doi: 10.1002/pst.1706. Epub 2015 Sep 9. Pharm Stat. 2015. PMID: 26353113

3

Bayesian adaptive dose-escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy.

Yeung WY, Reigner B, Beyer U, Diack C, Sabanés Bové D, Palermo G, Jaki T. Yeung WY, et al. Among authors: beyer u. Pharm Stat. 2017 Nov;16(6):396-413. doi: 10.1002/pst.1818. Epub 2017 Jul 9. Pharm Stat. 2017. PMID: 28691311

4

Rolling continual reassessment method with overdose control: An efficient and safe dose escalation design.

Zhu J, Sabanés Bové D, Liao Z, Beyer U, Yung G, Sarkar S. Zhu J, et al. Among authors: beyer u. Contemp Clin Trials. 2021 Aug;107:106436. doi: 10.1016/j.cct.2021.106436. Epub 2021 May 14. Contemp Clin Trials. 2021. PMID: 34000410

5

Issues in the assessment of non-inferiority: perspectives drawn from case studies.

Burger HU, Beyer U, Abt M. Burger HU, et al. Among authors: beyer u. Pharm Stat. 2011 Sep-Oct;10(5):433-9. doi: 10.1002/pst.512. Epub 2011 Sep 19. Pharm Stat. 2011. PMID: 21932300

6

A multistate model for early decision-making in oncology.

Beyer U, Dejardin D, Meller M, Rufibach K, Burger HU. Beyer U, et al. Biom J. 2020 May;62(3):550-567. doi: 10.1002/bimj.201800250. Epub 2019 Jul 16. Biom J. 2020. PMID: 31310368

7

Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.

Quiroz JA, Tamburri P, Deptula D, Banken L, Beyer U, Rabbia M, Parkar N, Fontoura P, Santarelli L. Quiroz JA, et al. Among authors: beyer u. JAMA Psychiatry. 2016 Jul 1;73(7):675-84. doi: 10.1001/jamapsychiatry.2016.0838. JAMA Psychiatry. 2016. PMID: 27304433 Clinical Trial.

8

Multistate model for pharmacometric analyses of overall survival in HER2-negative breast cancer patients treated with docetaxel.

Krishnan SM, Friberg LE, Bruno R, Beyer U, Jin JY, Karlsson MO. Krishnan SM, et al. Among authors: beyer u. CPT Pharmacometrics Syst Pharmacol. 2021 Oct;10(10):1255-1266. doi: 10.1002/psp4.12693. Epub 2021 Aug 3. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34313026 Free PMC article.

9

A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus.

Ikeda S, Takano Y, Cynshi O, Tanaka R, Christ AD, Boerlin V, Beyer U, Beck A, Ciorciaro C, Meyer M, Kadowaki T. Ikeda S, et al. Among authors: beyer u. Diabetes Obes Metab. 2015 Oct;17(10):984-93. doi: 10.1111/dom.12538. Epub 2015 Aug 20. Diabetes Obes Metab. 2015. PMID: 26179482 Clinical Trial.

10

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy.

Hodi FS, Ballinger M, Lyons B, Soria JC, Nishino M, Tabernero J, Powles T, Smith D, Hoos A, McKenna C, Beyer U, Rhee I, Fine G, Winslow N, Chen DS, Wolchok JD. Hodi FS, et al. Among authors: beyer u. J Clin Oncol. 2018 Mar 20;36(9):850-858. doi: 10.1200/JCO.2017.75.1644. Epub 2018 Jan 17. J Clin Oncol. 2018. PMID: 29341833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page